Patents by Inventor Marie GODAR

Marie GODAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109960
    Abstract: The instant disclosure provides isolated antibodies that specifically bind to IL-9 (e.g., human IL-9 or mouse IL-9). Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
    Type: Application
    Filed: December 14, 2023
    Publication date: April 4, 2024
    Inventors: Christophe BLANCHETOT, Marie GODAR
  • Publication number: 20200399382
    Abstract: The present invention relates to combination therapies and to their use in the treatment of chronic airway disease, particularly use in the treatment of asthma. The combination therapies comprise (i) an antagonist of IL-5:IL-5R and (ii) an antagonist of IL-4:IL-4R and/or an antagonist of IL-13:IL-13R. The present invention also provides bispecific antibodies comprising an antigen binding domain that binds to IL-4R? and an antigen binding domain that binds to IL-5. The bispecific antibodies may be used for the treatment of chronic airway disease, particularly asthma.
    Type: Application
    Filed: February 15, 2019
    Publication date: December 24, 2020
    Inventors: Christophe BLANCHETOT, Marie GODAR, Bart LAMBRECHT